ScholarIQanswers from OpenAlex

Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor

PaperCitations, authors & open-access status

Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor have?

ScholarIQcitation count

Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor has 56 citations in the OpenAlex counts ScholarIQ stores.

When was Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor published?

ScholarIQyear

Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor has 2019 year in the ScholarIQ index.

What is the open-access status of Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor?

ScholarIQoa status

Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor has closed oa status in the ScholarIQ index.

What is the DOI of Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor?

ScholarIQdoi

The DOI for Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor is on the source record.

What is the PMID of Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor?

ScholarIQpmid

The PMID for Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor is on the source record.

What is the OpenAlex record for Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor?

ScholarIQopenalex

The OpenAlex for Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial